{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:28Z","timestamp":1787496868066,"version":"build-2736575974"},"reference-count":93,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Introduction. Psoriasis is a chronic inflammatory skin disease and is the result of the interaction between numerous external and internal factors. Psoriasis presents a wide range of skin manifestations encompassing individual lesions varying from pinpoint to large plaques that can evolve into generalised forms. The lesions mirror the pathophysiological mechanisms involved in psoriasis pathogenesis, such as inflammation, dysregulation of immune response, uncontrolled proliferation of keratinocytes and angiogenesis. In this article, we present the latest advances achieved regarding markers that correlate with psoriasis severity. Material and method. We have performed a narrative review on markers of psoriasis severity, including articles published between March 2018\u2013March 2023. Results. We have identified four categories of markers: inflammation markers, oxidative stress markers, hormonal markers and cancer-related markers. The main focus was on inflammation biomarkers, including immunomodulatory molecules, haematological parameters, inflammatory cells and costimulatory molecules. Conclusions. The analysed data indicate that markers associated with inflammation, oxidative stress and hormones, and cancer-related markers could be useful in assessing the severity of psoriasis. Nevertheless, additional research is required to ascertain the practical importance of these biomarkers in clinical settings.<\/jats:p>","DOI":"10.3390\/medicina60020337","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T11:23:57Z","timestamp":1708341837000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Psoriasis: What Is New in Markers of Disease Severity?"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-7648","authenticated-orcid":false,"given":"Mircea","family":"Tampa","sequence":"first","affiliation":[{"name":"Department of Dermatology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, \u2018Victor Babes\u2019 Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina Irina","family":"Mitran","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Iulia","family":"Mitran","sequence":"additional","affiliation":[{"name":"Department of Microbiology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Matei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Roxana","family":"Georgescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, \u2018Victor Babes\u2019 Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: A Brief Overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/adt.2023.014","article-title":"Psoriasis: Striving for Potential Biomarkers","volume":"21","author":"Dan","year":"2023","journal-title":"ASSAY Drug Dev. Technol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., and Ohtsuki, M. (2019). Risk Factors for the Development of Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184347"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental Risk Factors and Epigenetic Alternations in Psoriasis","volume":"27","author":"Roszkiewicz","year":"2020","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2340\/00015555-2312","article-title":"Hormonal Factors and Risk of Psoriasis in Women: A Cohort Study","volume":"96","author":"Wu","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2249834","DOI":"10.1155\/2022\/2249834","article-title":"Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches","volume":"2022","author":"Medovic","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_8","first-page":"626","article-title":"Psoriasis","volume":"87","author":"Weigle","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.47162\/RJME.62.4.02","article-title":"Novel Concepts in Psoriasis: Histopathology and Markers Related to Modern Treatment Approaches","volume":"62","author":"Mihu","year":"2021","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2340\/00015555-3386","article-title":"Psoriasis and Treatment: Past, Present and Future Aspects","volume":"100","author":"Reid","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40257-017-0274-0","article-title":"Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients","volume":"18","author":"Eriksson","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/ijd.IJD_53_18","article-title":"Evaluation of Neopterin Level and Disease Severity in Patients with Psoriasis Vulgaris Treated with Narrowband UVB","volume":"64","author":"Kemeriz","year":"2019","journal-title":"Indian J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ijd.14217","article-title":"Serum Elafin as a Potential Inflammatory Marker in Psoriasis","volume":"58","author":"Elgharib","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.2147\/JIR.S378953","article-title":"Fibrinogen-like Protein 1 as a Novel Biomarker of Psoriasis Severity","volume":"15","author":"Sun","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e14606","DOI":"10.1111\/dth.14606","article-title":"Serum YKL-40 and IL 17 in Psoriasis: Reliability as Prognostic Markers for Disease Severity and Responsiveness to Treatment","volume":"34","author":"Khashaba","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_18","first-page":"593","article-title":"Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity","volume":"20","author":"Akbari","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.4081\/dr.2022.9469","article-title":"Increased Plasma Lipocalin-2 Levels Correlate with Disease Severity and May Be a Marker of Acute Inflammatory Response in Patients with Psoriasis","volume":"14","author":"Nguyen","year":"2022","journal-title":"Dermatol. Rep."},{"key":"ref_20","first-page":"1329","article-title":"Lesional Upregulation of SLURP1 Immunostaining Parallels Disease Severity in Psoriasis Vulgaris Patients","volume":"16","author":"Assaf","year":"2018","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.36849\/JDD.6127","article-title":"Platelet Count, Mean Platelet Volume, and Red Cell Distribution Width as Markers for Psoriasis Severity","volume":"21","author":"Nageen","year":"2022","journal-title":"J. Drugs Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","article-title":"Increased Peripheral Helper T Cells Type 17 Subset Correlates with the Severity of Psoriasis Vulgaris","volume":"229","author":"Liu","year":"2021","journal-title":"Immunol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jdermsci.2018.01.005","article-title":"Up-Regulated Expression of CD86 on Circulating Intermediate Monocytes Correlated with Disease Severity in Psoriasis","volume":"90","author":"Nguyen","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jdermsci.2017.11.007","article-title":"The Expression of mCTLA-4 in Skin Lesion Inversely Correlates with the Severity of Psoriasis","volume":"89","author":"Liu","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/jocd.14273","article-title":"Psoriasis: Embarking a Dynamic Shift in the Skin Microbiota","volume":"21","author":"Gupta","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Olejniczak-Staruch, I., Ci\u0105\u017cy\u0144ska, M., Sobolewska-Sztychny, D., Narbutt, J., Skibi\u0144ska, M., and Lesiak, A. (2021). Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083998"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tashiro, T., and Sawada, Y. (2022). Psoriasis and Systemic Inflammatory Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084457"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"925503","DOI":"10.3389\/fimmu.2022.925503","article-title":"Impact of Chronic Inflammation in Psoriasis on Bone Metabolism","volume":"13","author":"Saalbach","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3906\/sag-1402-14","article-title":"Neopterin, Homocysteine, and ADMA Levels during and after Urticaria Attack","volume":"45","author":"Tuncer","year":"2015","journal-title":"Turk. J. Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/JIR.S290264","article-title":"Neopterin: A Promising Candidate Biomarker for Severe COVID-19","volume":"14","author":"Hailemichael","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_31","first-page":"81","article-title":"Evaluation of Neopterin Level and Disease Severity in Patients with Psoriasis Vulgaris Treated with Narrowband UVB","volume":"6","author":"Hegazy","year":"2023","journal-title":"SVU-Int. J. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1346-8138.2009.00622.x","article-title":"Effects of Etanercept on Urine Neopterin Levels in Patients with Psoriasis in a Controlled, Open-label Study","volume":"36","author":"Koc","year":"2009","journal-title":"J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"516078","DOI":"10.3389\/fimmu.2021.516078","article-title":"Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide","volume":"12","author":"Carbonell","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Holmannova, D., Borsky, P., Borska, L., Andrys, C., Hamakova, K., Rehacek, V., Svadlakova, T., Malkova, A., Beranek, M., and Palicka, V. (2020). Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165617"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular Classification of Psoriasis Disease-Associated Genes through Pharmacogenomic Expression Profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenom. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1523-1747.ep12612749","article-title":"Levels of Skin-Derived Antileukoproteinase (SKALP)\/Elafin in Serum Correlate with Disease Activity During Treatment of Severe Psoriasis with Cyclosporin A","volume":"104","author":"Alkemade","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"767868","DOI":"10.3389\/fimmu.2021.767868","article-title":"Fibrinogen-like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.7150\/ijbs.67587","article-title":"The Role of YKL-40 in the Pathogenesis of Autoimmune Diseases: A Comprehensive Review","volume":"18","author":"Tizaoui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09546634.2017.1330529","article-title":"Serum YKL-40 as a Potential Biomarker of Inflammation in Psoriasis","volume":"29","author":"Baran","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"21438","DOI":"10.1038\/s41598-021-00999-9","article-title":"Biomarkers of Subclinical Atherosclerosis in Patients with Psoriasis","volume":"11","author":"Kaiser","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Jaberi, S.A., Cohen, A., D\u2019Souza, C., Abdulrazzaq, Y.M., Ojha, S., Bastaki, S., and Adeghate, E.A. (2021). Lipocalin-2: Structure, Function, Distribution and Role in Metabolic Disorders. Biomed. Pharmacother., 142.","DOI":"10.1016\/j.biopha.2021.112002"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","article-title":"Circulating Levels of Lipocalin-2 and Retinol-Binding Protein-4 Are Increased in Psoriatic Patients and Correlated with Baseline PASI","volume":"305","author":"Carrascosa","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09546634.2016.1180340","article-title":"Effect of Psoriasis Activity and Topical Treatment on Serum Lipocalin-2 Levels","volume":"28","author":"Baran","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbrc.2019.07.123","article-title":"The Secreted Ly-6\/uPAR Related Protein-1 (SLURP1) Stabilizes Epithelial Cell Junctions and Suppresses TNF-\u03b1-Induced Cytokine Production","volume":"517","author":"Campbell","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2021.12.006","article-title":"Secreted Ly-6\/uPAR-Related Protein-1 (SLURP1) Is a pro-Differentiation Factor That Stalls G1-S Transition during Corneal Epithelial Cell Cycle Progression","volume":"24","author":"Swamynathan","year":"2022","journal-title":"Ocul. Surf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.intimp.2015.05.030","article-title":"Transcriptional Regulation of SLURP2, a Psoriasis-Associated Gene, Is under Control of IL-22 in the Skin: A Special Reference to the Nested Gene LYNX1","volume":"29","author":"Moriwaki","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_48","first-page":"199","article-title":"Is There Any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients under Treatment for Psoriasis?","volume":"26","author":"Balevi","year":"2018","journal-title":"ACTA Dermatovenerol. Croat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","article-title":"Mean Platelet Volume in Psoriasis and Psoriatic Arthritis","volume":"29","author":"Canpolat","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mehy.2017.05.031","article-title":"Monocyte Subpopulations Study in Patients with Plaque Psoriasis","volume":"104","author":"Costa","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/keh663","article-title":"Aberrant Production of Soluble Costimulatory Molecules CTLA-4, CD28, CD80 and CD86 in Patients with Systemic Lupus Erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/ijd.IJD_327_18","article-title":"The Relationship between Tissue Thioredoxin Reductase Activity and the Psoriasis Area and Severity Index","volume":"65","author":"Kiafar","year":"2020","journal-title":"Indian J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Tampa, M., Mitran, C.I., Mitran, M.I., Amuzescu, A., Matei, C., and Georgescu, S.R. (2022). Ischemia-Modified Albumin\u2014A Potential New Marker of Oxidative Stress in Dermatological Diseases. Medicina, 58.","DOI":"10.3390\/medicina58050669"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.abd.2020.02.008","article-title":"Evaluation of Monocyte to HDL Cholesterol Ratio and Other Inflammatory Markers in Patients with Psoriasis","volume":"95","author":"Sirin","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_55","first-page":"38","article-title":"The serum level of oxidative stress and antioxidant markers in patients with psoriasis: A cross-sectional study","volume":"14","author":"Shakoei","year":"2021","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5114\/ada.2017.71113","article-title":"An evaluation of thiol\/disulphide homeostasis in patients with psoriasis","volume":"34","author":"Kilic","year":"2017","journal-title":"Adv. Dermatol. Allergol.\/Post\u0119py Dermatol. Alergol."},{"key":"ref_57","first-page":"9086024","article-title":"Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?","volume":"2020","author":"Maciejczyk","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Guarneri, F., Custurone, P., Papaianni, V., and Gangemi, S. (2021). Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10010082"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.37358\/RC.17.1.5385","article-title":"Vitamin C and Thiobarbituric Acid Reactive Substances (TBARS) in Psoriasis Vulgaris Related to Psoriasis Area Severity Index (PASI)","volume":"68","author":"Tampa","year":"2017","journal-title":"Rev. Chim."},{"key":"ref_60","unstructured":"Chatterjee, S. (2016). Oxidative Stress and Biomaterials, Elsevier."},{"key":"ref_61","first-page":"522","article-title":"Oxidative Stress-Related Markers and Alopecia Areata through Latex Turbidimetric Immunoassay Method","volume":"53","author":"Georgescu","year":"2016","journal-title":"Mater. Plast"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ple\u0144kowska, J., Gabig-Cimi\u0144ska, M., and Mozolewski, P. (2020). Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176206"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Blagov, A., Sukhorukov, V., Guo, S., Zhang, D., Eremin, I., and Orekhov, A. (2023). The Role of Oxidative Stress in the Induction and Development of Psoriasis. Front. Biosci.-Landmark, 28.","DOI":"10.31083\/j.fbl2806118"},{"key":"ref_64","first-page":"675","article-title":"Oxidative Stress Involvement in Urticaria","volume":"34","author":"Riso","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e22313","DOI":"10.1096\/fj.202101772R","article-title":"Thioredoxin-Interacting Protein Regulates Keratinocyte Differentiation: Implication of Its Role in Psoriasis","volume":"36","author":"Hsiao","year":"2022","journal-title":"FASEB J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The Thioredoxin Antioxidant System","volume":"66","author":"Lu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5114\/ada.2016.61606","article-title":"The Correlation between the Psoriasis Area Severity Index and Ischemia-Modified Albumin, Mean Platelet Volume Levels in Patients with Psoriasis","volume":"4","author":"Cevizci","year":"2016","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.12669\/pjms.35.4.534","article-title":"The Relationship between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Diabetic Nephropathy: Diabetic Nephropathy","volume":"35","author":"Onalan","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"940","DOI":"10.53350\/pjmhs22164940","article-title":"Comparison between the Claudin-3 and the Ratio of Monocyte to High-Density Lipoprotein Cholesterol as Markers for Psoriasis in a Sample of Iraqi Patients","volume":"16","author":"Ahmed","year":"2022","journal-title":"Pak. J. Med. Health Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09907.x","article-title":"Is Serum Amyloid A Protein a Better Indicator of Inflammation in Severe Psoriasis?","volume":"163","author":"Dogan","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1684\/ejd.2019.3605","article-title":"Low Serum Testosterone Levels in Male Psoriasis Patients Correlate with Disease Severity","volume":"29","author":"Allam","year":"2019","journal-title":"Eur. J. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5114\/ada.2019.83975","article-title":"Adrenocorticotropin\/Cortisol Ratio\u2014A Marker of Psoriasis Severity","volume":"37","author":"Pietrzak","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ced.13228","article-title":"Association between Circulating Prolactin Levels and Psoriasis and Its Correlation with Disease Severity: A Meta-Analysis","volume":"43","author":"Lee","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid Hormones and Cardiovascular Disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_75","first-page":"234","article-title":"The Role of Estrogens and Estrogen Receptors in Melanoma Development and Progression","volume":"12","author":"Caruntu","year":"2016","journal-title":"Acta Endocrinol. Buchar."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.yhbeh.2012.02.023","article-title":"Pregnancy and Pregnancy-Associated Hormones Alter Immune Responses and Disease Pathogenesis","volume":"62","author":"Robinson","year":"2012","journal-title":"Horm. Behav."},{"key":"ref_77","first-page":"11","article-title":"The Role of Hormones in the Pathogenesis of Psoriasis Vulgaris","volume":"89","author":"Roman","year":"2016","journal-title":"Clujul Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000087012","article-title":"Neuroendocrine System of the Skin","volume":"211","author":"Slominski","year":"2005","journal-title":"Dermatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"590","DOI":"10.25259\/IJDVL_533_2021","article-title":"Skin as an Endocrine Organ: A Narrative Review","volume":"88","author":"Datta","year":"2022","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4049\/jimmunol.1400076","article-title":"Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis","volume":"194","author":"Schwinge","year":"2015","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"111350","DOI":"10.1016\/j.jpsychores.2023.111350","article-title":"Stress and Psoriasis: Exploring the Link through the Prism of Hypothalamo-Pituitary-Adrenal Axis and Inflammation","volume":"170","author":"Rajasekharan","year":"2023","journal-title":"J. Psychosom. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1684\/ejd.2022.4267","article-title":"Circadian Cortisol Profiles and Hair Cortisol Concentration in Patients with Psoriasis: Associations with Anxiety, Depressive Symptomatology and Disease Severity","volume":"32","author":"Repousi","year":"2022","journal-title":"Eur. J. Dermatol. EJD"},{"key":"ref_83","first-page":"888","article-title":"Immunohistochemical Study of Psoriatic Plaques and Perilesional Skin in Psoriasis Vulgaris Patients: A Pilot Study","volume":"18","author":"Morar","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4103\/0019-5154.143512","article-title":"Serum Prolactin Levels in Psoriasis and Its Association with Disease Activity: A Case-Control Study","volume":"59","author":"Keen","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zhu, H. (2022). Squamous Cell Carcinoma Antigen: Clinical Application and Research Status. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051065"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5823684","DOI":"10.1155\/2018\/5823684","article-title":"The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease","volume":"2018","author":"Tampa","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000488672","article-title":"Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity","volume":"234","author":"Sun","year":"2018","journal-title":"Dermatology"},{"key":"ref_88","first-page":"50","article-title":"Squamous Cell Carcinoma Antigen in Psoriasis: An Immunohistochemical Study","volume":"14","author":"Ghonemy","year":"2021","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","article-title":"Cytokines in psoriasis","volume":"100","author":"Reiche","year":"2021","journal-title":"Adv. Clin. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Georgescu, S.-R., Tampa, M., Caruntu, C., Sarbu, M.-I., Mitran, C.-I., Mitran, M.-I., Matei, C., Constantin, C., and Neagu, M. (2019). Advances in Understanding the Immunological Pathways in Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030739"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Winiarska-Mieczan, A., Mieczan, T., and W\u00f3jcik, G. (2020). Importance of Redox Equilibrium in the Pathogenesis of Psoriasis\u2014Impact of Antioxidant-Rich Diet. Nutrients, 12.","DOI":"10.3390\/nu12061841"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Marek-Jozefowicz, L., Czajkowski, R., Borkowska, A., Nedoszytko, B., \u017bmijewski, M.A., Cuba\u0142a, W.J., and Slominski, A.T. (2022). The Brain\u2013Skin Axis in Psoriasis\u2014Psychological, Psychiatric, Hormonal, and Dermatological Aspects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020669"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/13543784.2023.2219387","article-title":"The Holistic Approach to Psoriasis Patients with Comorbidities: The Role of Investigational Drugs","volume":"23","author":"Camela","year":"2023","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/2\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:45Z","timestamp":1760104905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/2\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":93,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["medicina60020337"],"URL":"https:\/\/doi.org\/10.3390\/medicina60020337","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,18]]}}}